Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute My... di Amir T. Fathi (15313195)

Altri autori: “...Haesook T. Kim (15313198)...”

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute My... di Amir T. Fathi (15313195)

Altri autori: “...Haesook T. Kim (15313198)...”